Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 1/20 | 0.31 |
| ▸ | CA1 | P00915 | 1/20 | 0.31 |
| ▸ | CA2 | P00918 | 1/20 | 0.31 |
| ▸ | CA9 | Q16790 | 1/20 | 0.31 |
| ▸ | HSD17B1 | P14061 | 1/20 | 0.30 |
| ▸ | HSD17B2 | P37059 | 1/20 | 0.30 |
| ▸ | FLT3 | P36888 | 1/20 | 0.30 |
| ▸ | BMX | P51813 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21453796 | 0.97 | FLT3 (0.32) | CA12CA1CA2CA9FLT3 | |
| SCHEMBL21454054 | 0.96 | CA12 (0.30) | CA12CA1CA2CA9 | |
| SCHEMBL21453843 | 0.94 | — | — | |
| SCHEMBL21454109 | 0.93 | FLT3 (0.31) | FLT3BMX | |
| SCHEMBL21453844 | 0.91 | FLT3 (0.30) | FLT3BMX | |
| SCHEMBL21454114 | 0.89 | HSD17B1 (0.36) | HSD17B1HSD17B2 | |
| SCHEMBL21453589 | 0.89 | CA12 (0.36) | CA12CA1CA2CA9FLT3 | |
| SCHEMBL21453795 | 0.85 | HSD17B1 (0.33) | HSD17B1HSD17B2 | |
| SCHEMBL21453596 | 0.85 | FLT3 (0.36) | CA12CA1CA2CA9FLT3 | |
| SCHEMBL21454229 | 0.84 | TSPO (0.38) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11038121-B2 | 9 membered ring carbazole compounds | Beijing Summer Sprout Technology Co., Ltd. (CN) | 2021-06-15 | — | — | US | disclosed |
| US-20190312214-A1 | 9 MEMBERED RING CARBAZOLE COMPOUNDS | BEIJING SUMMER SPROUT TECHNOLOGY CO., LTD (CN) | 2019-10-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11038121-B2 | 9 membered ring carbazole compounds | SLC25A21, OCIAD2, OXA1L | CA12 4292/4885CA1 4418/4885CA2 3460/4885 |
| US-20190312214-A1 | 9 MEMBERED RING CARBAZOLE COMPOUNDS | SLC25A21, OCIAD2, OXA1L | CA12 4292/4885CA1 4418/4885CA2 3460/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.